Literature DB >> 18042146

Combining array-based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms.

Inga Nieländer1, Stefanie Bug, Julia Richter, Maciej Giefing, José Ignacio Martín-Subero, Reiner Siebert.   

Abstract

Tumor suppressor gene (TSG) inactivation by chromosomal deletions and/or mutations is a well-characterized genetic alteration in lymphomas. Array-based technologies have greatly increased the detection and characterization of chromosomal imbalances and regions with loss of heterozygosity (LOH), leading to the identification of a number of novel candidate TSG loci. In addition, microarray platforms for studying DNA methylation and histone modifications enable identifying epigenetic changes affecting gene expression of TSG. Combining these microarray technologies with gene expression profiling is a promising strategy to discover novel TSG in regions targeted by genetic or epigenetic alterations. In this review we present an outline of methodological aspects of the various microarray technologies, and discuss their potentials and restrictions. Furthermore, we survey research findings derived from these high-throughput techniques, which are allowing a deeper insight into the mechanisms of lymphomagenesis.

Entities:  

Mesh:

Year:  2007        PMID: 18042146     DOI: 10.1111/j.1600-0463.2007.apm_883.xml.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Authors:  M Giefing; M Wierzbicka; K Szyfter; J C Brenner; B J Braakhuis; R H Brakenhoff; C R Bradford; J A Sorensen; A Rinaldo; J P Rodrigo; R P Takes; A Ferlito
Journal:  Eur J Cancer       Date:  2016-02-04       Impact factor: 9.162

2.  Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome.

Authors:  Eri Arai; Saori Ushijima; Hiroyuki Fujimoto; Fumie Hosoda; Tatsuhiro Shibata; Tadashi Kondo; Sana Yokoi; Issei Imoto; Johji Inazawa; Setsuo Hirohashi; Yae Kanai
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

3.  Biostable ssDNA aptamers specific for Hodgkin lymphoma.

Authors:  Parag Parekh; Sanchit Kamble; Nianxi Zhao; Zihua Zeng; Jianguo Wen; Bin Yuan; Youli Zu
Journal:  Sensors (Basel)       Date:  2013-10-25       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.